Notably, another important cell involved in the pathogenic process of RA is the fibroblast-like synoviocytes (FLSs), and there are more available studies that examine the effects of GLP-1RAs on FLSs
Estimated mean TMAO AUC, based on the linear mixed model, was 1,041 mol/L h for placebo and 1,048 mol/L h for pomegranate, with a (placebo/pomegranate) ratio of 0.993 (95% CI: 0.809, 1.22)
Currently, there is no FDA-approved indication for GLP-1 receptor agonists or GIP/GLP-1 dual agonists specifically for lipedema treatment, and high-quality clinical trial evidence remains limited
Light queasiness after meals, reduced appetite that feels manageable, occasional soft stools: these are signs that semaglutide is working and your GI system is adjusting
The long-term picture is actually more reassuring than the short-term one
doi:10.1164/rccm.200508-1223OC Singh TD, Patial K, Vijayan VK, Ravi K